Techniques: Combined testing of memory and brain glucose uptake for identifying prodromal-stage Alzheimer's disease (AD) patients

Assays and screens

TECHNOLOGY: Diagnostic assays

A combination of cognitive testing and brain imaging could help stratify prodromal-stage AD patients for clinical trials.

Read the full 212 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE